Clinical trial NCT03064997 - References

Celiac Disease — Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children

Citation(s)

•   Drabinska N, Jarocka-Cyrta E, Markiewicz LH, Krupa-Kozak U
  The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized,
•   Drabinska N, Jarocka-Cyrta E, Ratcliffe NM, Krupa-Kozak U
  The Profile of Urinary Headspace Volatile Organic Compounds After 12-Week Intake of Oligofructose-Enriched Inulin by Children and Adolescents with Celiac Disease on a Gluten-Free Diet: Results of
•   Drabinska N, Jarocka-Cyrta E, Zlotkowska D, Abramowicz P, Krupa-Kozak U
  Daily oligofructose-enriched inulin intake impacts bone turnover markers but not the cytokine profile in pediatric patients with celiac disease on a gluten-free diet: Results of a ra
•   Drabinska N, Krupa-Kozak U, Abramowicz P, Jarocka-Cyrta E
  Beneficial Effect of Oligofructose-Enriched Inulin on Vitamin D and E Status in Children with Celiac Disease on a Long-Term Gluten-Free Diet: A Preliminary Randomized, Placebo-Controlled Nutrition
•   Drabinska N, Krupa-Kozak U, Ciska E, Jarocka-Cyrta E
  Plasma profile and urine excretion of amino acids in children with celiac disease on gluten-free diet after oligofructose-enriched inulin intervention: results of a randomised placebo-controlled pilot
•   Ferus K, Drabinska N, Krupa-Kozak U, Jarocka-Cyrta E
  A Randomized, Placebo-Controlled, Pilot Clinical Trial to Evaluate the Effect of Supplementation with Prebiotic Synergy 1 on Iron Homeostasis in Children and Adolescents with Celiac Disease Treated wit

Assessment of the Impact of Prebiotic Synergy 1 on the Intestine Permeability, Clinical Symptoms, and Selected Biochemical and Nutritional Parameters in the Children With Celiac Disease on a Gluten-free Diet

Details for clinical trial NCT03064997